Computational Infrastructure for Modern Pharmaceuticals
Explaining Digital-Robotic Technology for Pharmaceutical R&D
We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest. For further information on how we process and monitor your personal data click here.
Over the last 150 years, the pharmaceutical industry has gone through different phases of transformation.
Every phase incorporated new technologies of the time: Synthetic chemistry in the late 19th century, molecular biology after WWII, and bioengineering in the late 20th century. In the last few years, we have been observing the beginning of another leap that is incorporating advanced computing technology and robotic automation. The word modern in the title refers to another phase of modernization.
This paper, authored by Alireza Shabani, Founder & CEO of Qulab, describes the necessary computational architecture for pharmaceutical firms to accelerate R&D and drug discovery, especially utilizing special purpose silicon and quantum processors.
Read the paper to learn about:
- A New Computing Frontier for Pharma R&D
- Application-Specific Integrated Circuits
- Quantum Computers
- Digitization and automation for Pharma R&D
Hear more from Qulab, and the future of quantum-enabled pharma at Quantum.Tech, September 10-11 2019, at the Sheraton Boston.
Download THE PAPER now